Juvenile arthritis (JA) is an umbrella term used to describe the many autoimmune and inflammatory conditions that can develop in children ages 16 and younger. The most common symptoms are limping, stiffness when awakening, reluctance to use an arm or leg, reduced activity level, persistent fever, joint swelling and difficulty with fine motor activities.
Anticyclic citrullinated peptide (anti-CCP) antibodies test, by finding the Rheumatoid factor (RF), Antinuclear antibody (ANA), C-reactive protein, Erythrocyte sedimentation rate (ESR or sed rate) and X Ray Juvenile Arthritis can be diagnosed.
Disease-modifying antirheumatic drugs (DMARDs), Nonsteroidal anti-inflammatory drugs (NSAIDs), Corticosteroids and biologic agents are used for treatment.
For more information visit the following websites